Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FU5YU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,493
Award facts
- Contract value 100% obligated
- $14,492.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 25, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections. The contract carries a ceiling value of $14,492.64 and is structured as a firm fixed price delivery order with an ultimate completion date of September 26, 2025. This award was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
The delivery order supports the Defense Logistics Agency's Medical Supply Chain mission, which provides pharmaceuticals and medical supplies to military healthcare systems and other federal health programs. Zepbound, a GLP-1 receptor agonist medication used in diabetes and weight management, exemplifies the range of specialty pharmaceuticals that AmerisourceBergen supplies through its federal contracts. The company's comprehensive pharmaceutical prime vendor arrangement with DLA enables it to fulfill medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities, demonstrating its critical role in supporting military medical readiness and veteran healthcare initiatives.
Quick answers
Who was awarded contract SPE2DB25FU5YU?
SPE2DB25FU5YU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FU5YU worth?
The government has obligated $14,493 on SPE2DB25FU5YU.
Is contract SPE2DB25FU5YU an order under another contract?
Yes. SPE2DB25FU5YU is a delivery order under SPE2DB22D2108, an indefinite delivery contract.
Was contract SPE2DB25FU5YU competed?
The extent of competition for SPE2DB25FU5YU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award